Diabetes has been incurable due to \u03b2-cell death and dysfunction in patients. \u03b2-cell preservation is thus emerging as a promising strategy to treat and reverse diabetes. A recent study by Dr. Wen-Chin Yang\u2019s research group at the Research Center of Agricultural Biotechnology, identified Pdia4, a key regulator of \u03b2-cell failure, as a novel therapeutic target of diabetes. Pre-clinical studies of a Pdia4 inhibitor, PS1, were completed and PS1 is now ready for the application of investigational drug to FDA and clinical trials. This study has been published in EMBO Molecular Medicine<\/em> on September, 2021.<\/p>\n
Article Link: https:\/\/www.embopress.org\/doi\/full\/10.15252\/emmm.201911668<\/a><\/p>\n